X hits on this document

Word document

SAINT-PETERSBURG – 2010 - page 74 / 128

325 views

0 shares

0 downloads

0 comments

74 / 128

State educational institution of higher professional education «Tver State Medical Academy». Russia, 170100, Tver, Sovetskaya str., 4. Тel.: 8(4822)32-17-79, fax: 8(4822)34-43-09. Е-mail: info@tvergma.ru

Summary: Clinical blood analysis of patients with prostate cancer showed significant leucocyte decrease. Features of immunoreactivity in patients with benign prostate hyperplasia include immune lack of CD8 and CD19 cells.  While in patients with prostate cancer there was more marked decrease of CD3, CD4, CD8 and CD19 lymphocytes.

Key words: benign prostate hyperplasia; prostate cancer; immune reactivity.

References

1. Клиническая онкоурология / под ред. Б.П. Матвеева. – М.:Вердана, 2003. - 457с.

2. Лимфоциты / под ред. Дж. Клауса. – М.: Мир, 1990. – 95 с.

3. Урология / под ред. Н.А. Лопаткина. - М.: ГЕОТАР-МЕДИА, 2007. –265 с.

4. Guess H.A. Epidemiology and natural history of benign prostatic hyperplasia / H.A. Guess // Urol. Clin. North. Am. - 1995. - Vol. 22. - P. 247-261.

5. Quinn M. Patterns and trends in prostata cancer incidence, survival, prevalence and mortality / M. Quinn, P. Babb // International comparisons BJU. Int. - 2002. - Vol. 90. - № 2. - Р. 162-173.

Сведения об авторах:

Information about the authors:

Material Received 31.10.2009 г.

1328 Селиверстов+

UDC 616.34-008.87-07:616.36-002.2

© P.V. Seliverstov, L.A. Teterina, V.G. Radchenko, S.I. Sitkin, A.N. Suvorov, G.G. Alekhina, 2010

Document info
Document views325
Page views325
Page last viewedWed Dec 07 10:50:31 UTC 2016
Pages128
Paragraphs1794
Words33610

Comments